Qualys reports the discovery by their threat research unit of vulnerabilities in the Linux AppArmor system used by SUSE, Debian, Ubuntu, and ...

A second phase 3 study of Roche’s fenebrutinib in relapsing multiple sclerosis (RMS) has hit its primary endpoint, positioning the company to submit the BTK inhibitor for approval. But the discovery ...

America’s power supply is stretched to the breaking point. The North American Electric Reliability Corp. (NERC), the nation’s grid reliability watchdog, recently found that more than half the nation ...

Claude can turn any list of events—even a paper one—into an iCal file. I rely heavily on my digital calendar—as far as I'm concerned, if something isn't there, it doesn't exist. It's annoying, then, ...

Penny Gusner is a senior insurance writer and analyst at Forbes Advisor. For more than 20 years, she has been helping consumers learn how insurance laws, data, trends, and coverages affect them. Penny ...

Newspapers report daily on the frantic efforts by elected officials to address America’s housing affordability crisis, including a recent story that President Donald Trump called Sen. Elizabeth Warren ...

SEATTLE — Multiple airlines are stepping up to ensure Seattle fans can cheer on their team at the Big Game in person. 12s are scrambling to book their travel plans after the Seahawks' breathtaking ...

Khamosh Pathak is a freelance tech journalist with over 13 years of experience writing online. An accounting graduate, he turned his interest in writing and technology into a career. He holds a ...

Teclistamab-cqyv significantly improves progression-free and overall survival in relapsed/refractory multiple myeloma, especially in patients refractory to anti-CD38 therapy and lenalidomide. The ...

If you’re a regular reader of my column, you’ve likely heard me say before that transplant patients commit to a lifetime of medical surveillance. As of Jan. 7, I’ve had 139 medication changes since I ...